Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (IgG-Fv) (BSGV-176)

Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-IL17A antibody variable domain is fused to the C terminal of an IgG of anti-IL17F antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Multiple sclerosis (MS); Autoimmune diseases; Inflammatory diseases therapy.

Datasheet INQUIRY

Specifications

Targets

IL17A & IL17F

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Multiple sclerosis (MS); Autoimmune diseases; Inflammatory diseases

Targets

Target 1

IL17A

Gene ID

3605

UniProt ID

Q16552

Alternative Names

IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)

Target 2

IL17F

Gene ID

112744

UniProt ID

Q96PD4

Alternative Names

IL17; Interleukin 17; IL17F; Interleukin 17F; ML1; ML-1; CANDF6; IL-17F; cytokine ML-1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (IgG-Fv) (BSGV-176). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (IgG-Fv) (CAT#: BSGV-176)

Specifications

Targets

Customer Reviews and Q&As